RN7SL733P

Across TCGA pan-cancer cohorts, RN7SL733P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL733P’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RN7SL733P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL733P is over-expressed in tumor, although a few such as PAAD and THCA show the opposite, repressed pattern.

PAAD, PRAD, and THCA are the cancer types where RN7SL733P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL733P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.285	.048	2	view →
PRAD	All	All	+0.109	.028	2	view →
THCA	Female	All	−0.107	.005	2	view →
KIRC	All	All	+0.055	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL733P–PAAD

Open the PAAD breakdown →